Smith, Moore & Co’s Novo Nordisk NVO Stock Holding History

Smith, Moore & Co’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$202K	Buy
2024 Q4	–	Sell
2024 Q3	$329K	Sell
2024 Q2	$585K	Buy
2024 Q1	$503K	Buy
2023 Q4	$383K	Buy
2023 Q3	$273K	Buy